With the rapid development of the company in 2018, Belief BioMed plans to build a new GMP manufacturing plant to meet the expanding demand in the future. The new plant covers an area of 5000m² and has multiple production facilities capable of producing adeno-associated virus (AAV) vectors for gene therapy, as well as quality control laboratory and warehousing. Initially, the plant will be used for R&D, manufacturing and quality control, but it is large enough to accommodate future expansion.

On January 27, 2019, the commencement ceremony of the new plant was hold in ECUST Science and Technology Park. Sherpa Venture Capital's founding partner, Meilong town government leaders and other officials attended the event. “The new plant will bring the Scalability of our products to 250L, and we expected to employ over 100 people for this site by the end of 2020.” CEO Dr. Zheng Jing of Belief BioMed said.